142 related articles for article (PubMed ID: 24886209)
1. Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.
Uchida K; Veeramachaneni R; Huey B; Bhattacharya A; Schmidt BL; Albertson DG
BMC Cancer; 2014 May; 14():353. PubMed ID: 24886209
[TBL] [Abstract][Full Text] [Related]
2. Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis.
Bhattacharya A; Roy R; Snijders AM; Hamilton G; Paquette J; Tokuyasu T; Bengtsson H; Jordan RC; Olshen AB; Pinkel D; Schmidt BL; Albertson DG
Clin Cancer Res; 2011 Nov; 17(22):7024-34. PubMed ID: 22068658
[TBL] [Abstract][Full Text] [Related]
3. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
[TBL] [Abstract][Full Text] [Related]
4. NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva.
Guerrero-Preston R; Soudry E; Acero J; Orera M; Moreno-López L; Macía-Colón G; Jaffe A; Berdasco M; Ili-Gangas C; Brebi-Mieville P; Fu Y; Engstrom C; Irizarry RA; Esteller M; Westra W; Koch W; Califano J; Sidransky D
Cancer Prev Res (Phila); 2011 Jul; 4(7):1061-72. PubMed ID: 21558411
[TBL] [Abstract][Full Text] [Related]
5. Altered histone mark deposition and DNA methylation at homeobox genes in human oral squamous cell carcinoma.
Marcinkiewicz KM; Gudas LJ
J Cell Physiol; 2014 Oct; 229(10):1405-16. PubMed ID: 24519855
[TBL] [Abstract][Full Text] [Related]
6. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
Kordowski F; Kolarova J; Schafmayer C; Buch S; Goldmann T; Marwitz S; Kugler C; Scheufele S; Gassling V; Németh CG; Brosch M; Hampe J; Lucius R; Röder C; Kalthoff H; Siebert R; Ammerpohl O; Reiss K
BMC Cancer; 2018 Aug; 18(1):796. PubMed ID: 30081852
[TBL] [Abstract][Full Text] [Related]
7. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
Wang K; Jin J; Ma T; Zhai H
J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
[TBL] [Abstract][Full Text] [Related]
8.
Imai A; Mochizuki D; Misawa Y; Nakagawa T; Endo S; Mima M; Yamada S; Kawasaki H; Kanazawa T; Misawa K
DNA Cell Biol; 2019 Jul; 38(7):678-687. PubMed ID: 31188017
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
11. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
[TBL] [Abstract][Full Text] [Related]
12. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic deregulation of the anaplastic lymphoma kinase gene modulates mesenchymal characteristics of oral squamous cell carcinomas.
Huang TT; Gonzales CB; Gu F; Hsu YT; Jadhav RR; Wang CM; Redding SW; Tseng CE; Lee CC; Thompson IM; Chen HR; Huang TH; Kirma NB
Carcinogenesis; 2013 Aug; 34(8):1717-27. PubMed ID: 23568951
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
Clausen MJ; Melchers LJ; Mastik MF; Slagter-Menkema L; Groen HJ; van der Laan BF; van Criekinge W; de Meyer T; Denil S; Wisman GB; Roodenburg JL; Schuuring E
Genes Chromosomes Cancer; 2016 Jan; 55(1):45-59. PubMed ID: 26391330
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.
Zhou C; Li J; Li Q; Liu H; Ye D; Wu Z; Shen Z; Deng H
J Clin Lab Anal; 2019 Jun; 33(5):e22873. PubMed ID: 30843252
[TBL] [Abstract][Full Text] [Related]
16. Promoter DNA Methylation and mRNA Expression Level of p16 Gene in Oral Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics.
Allameh A; Moazeni-Roodi A; Harirchi I; Ravanshad M; Motiee-Langroudi M; Garajei A; Hamidavi A; Mesbah-Namin SA
Pathol Oncol Res; 2019 Oct; 25(4):1535-1543. PubMed ID: 30511108
[TBL] [Abstract][Full Text] [Related]
17. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients.
Lissa D; Ishigame T; Noro R; Tucker MJ; Bliskovsky V; Shema S; Beck JA; Bowman ED; Harris CC; Robles AI
Lung Cancer; 2018 Aug; 122():151-159. PubMed ID: 30032824
[TBL] [Abstract][Full Text] [Related]
18. Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma.
Strzelczyk JK; Krakowczyk Ł; Owczarek AJ
Arch Oral Biol; 2019 Feb; 98():265-272. PubMed ID: 30576962
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic repression of HOXB cluster in oral cancer cell lines.
Xavier FC; Destro MF; Duarte CM; Nunes FD
Arch Oral Biol; 2014 Aug; 59(8):783-9. PubMed ID: 24859765
[TBL] [Abstract][Full Text] [Related]
20. Application of Random Forest and data integration identifies three dysregulated genes and enrichment of Central Carbon Metabolism pathway in Oral Cancer.
Mukhopadhyay S; Ghosh S; Das D; Arun P; Roy B; Biswas NK; Maitra A; Majumder PP
BMC Cancer; 2020 Dec; 20(1):1219. PubMed ID: 33317464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]